Which test is used to detect active infectious mononucleosis?

Testing for Active Infectious Mononucleosis

The heterophile antibody test (monospot) is the most cost-effective initial test for diagnosing active infectious mononucleosis, with 87% sensitivity and 91% specificity, though it should be combined with a complete blood count showing >40% lymphocytes and >10% atypical lymphocytes. 1

Initial Diagnostic Approach

For suspected acute infectious mononucleosis, the recommended initial testing strategy includes:

• Heterophile antibody test (monospot): This rapid, inexpensive test is the classic diagnostic method for infectious mononucleosis 1, 2
• Complete blood count with differential: Look for >40% total lymphocytes and >10% atypical lymphocytes 1

The combination of these two tests provides cost-effective, efficient initial evaluation 1.

Important Caveats and Limitations

False-Negative Heterophile Testing

The heterophile antibody test has significant limitations in specific populations:

• Children under 5 years: The test can yield false-negative results in young children 1
• Early illness (first week): Adults tested during the first week of symptoms may have false-negative results 1
• Lower specificity than reported: Recent data shows specificity may be as low as 90.6% with a positive predictive value of only 36.4% in collegiate athletes 3

Positive monospot results should be confirmed with EBV antibody testing, as a positive test alone is insufficient for diagnosis 3.

Confirmatory Testing When Monospot is Negative

When clinical suspicion remains high despite negative heterophile testing:

• EBV viral capsid antigen (VCA) antibody testing: This is more sensitive and specific than the heterophile test but is more expensive and takes longer to process 1, 4
• Elevated liver transaminases: The presence of elevated liver enzymes increases clinical suspicion for infectious mononucleosis and is highly correlated with acute disease 1, 3
• All athletes diagnosed with infectious mononucleosis had elevated liver transaminases 3

Age-Specific Testing Considerations

Children Under 6 Years

For younger children, testing strategy should be modified:

• Plasma EBV-DNA testing: This has higher diagnostic value than VCA-IgG avidity testing in children <6 years, especially those <3 years 5
• Sensitivity and specificity: EBV-DNA testing shows 98.27% sensitivity and 91.13% specificity 5
• Combined approach: EBV antibody detection should be combined with EBV nucleic acid detection in children <6 years 5

Adolescents and Young Adults

For the typical age group (15-24 years):

• Standard heterophile antibody testing with CBC differential is appropriate 1
• The peripheral lymphocyte test (lymphocytosis >5 × 10⁹/L) shows 93.08% sensitivity and 87.77% specificity 5

Timing of Testing

The optimal test varies by disease stage:

• Early stage (first week): Peripheral lymphocyte test and plasma EBV-DNA test are more suitable 5
• After 7 days of illness: VCA-IgG avidity test becomes more reliable 5

Most Accurate (But Expensive) Testing

When definitive diagnosis is required:

• EBV viral capsid antigen antibody testing: Most sensitive and specific option 4
• EBV nuclear antigen antibodies: Also highly sensitive and specific 4
• PCR for EBV DNA: More sensitive than heterophile testing in children, highly specific, but expensive 4

The VCA-IgG avidity test demonstrates 84.08% sensitivity and 96.33% specificity 5.